135 related articles for article (PubMed ID: 7238561)
1. Plasma propranolol steady state concentrations in thyroid disorders.
Feely J; Crooks J; Stevenson IH
Eur J Clin Pharmacol; 1981; 19(5):329-33. PubMed ID: 7238561
[TBL] [Abstract][Full Text] [Related]
2. Plasma protein binding of propranolol and isoprenaline in hyperthyroidism and hypothyroidism.
Kelly JG; McDevitt DG
Br J Clin Pharmacol; 1978 Aug; 6(2):123-7. PubMed ID: 678388
[TBL] [Abstract][Full Text] [Related]
3. The influence of age, smoking and hyperthyroidism on plasma propranolol steady state concentration.
Feely J; Crooks J; Stevenson IH
Br J Clin Pharmacol; 1981 Jul; 12(1):73-8. PubMed ID: 6264937
[TBL] [Abstract][Full Text] [Related]
4. Altered plasma protein binding of drugs in thyroid disease.
Feely J; Stevenson IH; Crooks J
Clin Pharmacokinet; 1981; 6(4):298-305. PubMed ID: 7249488
[TBL] [Abstract][Full Text] [Related]
5. Propranolol, triiodothyronine, reverse triiodothyronine and thyroid disease.
Feely J; Isles TE; Ratcliffe WA; Crooks J
Clin Endocrinol (Oxf); 1979 May; 10(5):531-8. PubMed ID: 476982
[TBL] [Abstract][Full Text] [Related]
6. Visfatin plasma concentrations in patients with hyperthyroidism and hypothyroidism before and after control of thyroid function.
Ozkaya M; Sahin M; Cakal E; Yuzbasioglu F; Sezer K; Kilinc M; Imrek SS
J Endocrinol Invest; 2009 May; 32(5):435-9. PubMed ID: 19498324
[TBL] [Abstract][Full Text] [Related]
7. The effect of iodide on serum thyroid hormone levels in normal persons, in hyperthyroid patients, and in hypothyroid patients on thyroxine replacement.
Philippou G; Koutras DA; Piperingos G; Souvatzoglou A; Moulopoulos SD
Clin Endocrinol (Oxf); 1992 Jun; 36(6):573-8. PubMed ID: 1424182
[TBL] [Abstract][Full Text] [Related]
8. Individual plasma ghrelin changes in the same patients in hyperthyroid, hypothyroid and euthyroid state.
Ruchala M; Gurgul E; Stangierski A; Wrotkowska E; Moczko J
Peptides; 2014 Jan; 51():31-4. PubMed ID: 24184592
[TBL] [Abstract][Full Text] [Related]
9. Plasma cyclic AMP response to glucagon as an index of tissue responsiveness to thyroid hormone.
Paisey R; Elkeles RS; Hambley J; Belchetz PE
Diabete Metab; 1978 Dec; 4(4):267-70. PubMed ID: 215472
[TBL] [Abstract][Full Text] [Related]
10. Changes in plasma low-density lipoprotein (LDL)- and high-density lipoprotein cholesterol in hypo- and hyperthyroid patients are related to changes in free thyroxine, not to polymorphisms in LDL receptor or cholesterol ester transfer protein genes.
Diekman MJ; Anghelescu N; Endert E; Bakker O; Wiersinga WM
J Clin Endocrinol Metab; 2000 May; 85(5):1857-62. PubMed ID: 10843165
[TBL] [Abstract][Full Text] [Related]
11. Plasma levels of NT-pro-brain natriuretic peptide in patients with overt and subclinical hyperthyroidism and hypothyroidism.
Pakuła D; Marek B; Kajdaniuk D; Krysiak R; Kos-Kudła B; Pakuła P; Gatnar A; Borgiel-Marek H; Nowak M; Siemińska L; Głogowska-Szeląg J; Ostrowska Z
Endokrynol Pol; 2011; 62(6):523-8. PubMed ID: 22144219
[TBL] [Abstract][Full Text] [Related]
12. Effect of thyroid function on LDL oxidation in hypothyroidism and hyperthyroidism.
Oge A; Sozmen E; Karaoglu AO
Endocr Res; 2004 Aug; 30(3):481-9. PubMed ID: 15554363
[TBL] [Abstract][Full Text] [Related]
13. Correlation of platelet taurine levels with thyroid function.
Baskin SI; Klekotka SJ; Kendrick ZV; Bartuska DG
J Endocrinol Invest; 1979; 2(3):245-9. PubMed ID: 528776
[TBL] [Abstract][Full Text] [Related]
14. Leptin and the pituitary-thyroid axis: a comparative study in lean, obese, hypothyroid and hyperthyroid subjects.
Pinkney JH; Goodrick SJ; Katz J; Johnson AB; Lightman SL; Coppack SW; Mohamed-Ali V
Clin Endocrinol (Oxf); 1998 Nov; 49(5):583-8. PubMed ID: 10197072
[TBL] [Abstract][Full Text] [Related]
15. Influence of surgery on plasma propranolol levels and protein binding.
Feely J; Forrest A; Gunn A; Hamilton W; Stevenson I; Crooks J
Clin Pharmacol Ther; 1980 Dec; 28(6):759-64. PubMed ID: 7438691
[TBL] [Abstract][Full Text] [Related]
16. Thyroid hormones and atrial natriuretic hormone secretion: study in hyper- and hypothyroid patients.
Rolandi E; Santaniello B; Bagnasco M; Cataldi A; Garibaldi C; Franceschini R; Barreca T
Acta Endocrinol (Copenh); 1992 Jul; 127(1):23-6. PubMed ID: 1387755
[TBL] [Abstract][Full Text] [Related]
17. Impact of thyroid dysfunction on serum cystatin C.
Fricker M; Wiesli P; Brändle M; Schwegler B; Schmid C
Kidney Int; 2003 May; 63(5):1944-7. PubMed ID: 12675875
[TBL] [Abstract][Full Text] [Related]
18. Multicenter study on the prevalence of sexual symptoms in male hypo- and hyperthyroid patients.
Carani C; Isidori AM; Granata A; Carosa E; Maggi M; Lenzi A; Jannini EA
J Clin Endocrinol Metab; 2005 Dec; 90(12):6472-9. PubMed ID: 16204360
[TBL] [Abstract][Full Text] [Related]
19. The effects of thyroid status on plasma leptin levels in women.
Ozata M; Ozisik G; Bingol N; Corakci A; Gundogan MA
J Endocrinol Invest; 1998 Jun; 21(6):337-41. PubMed ID: 9699123
[TBL] [Abstract][Full Text] [Related]
20. Plasma lipoprotein (a) concentrations in hypothyroid, euthyroid and hyperthyroid subjects.
Erem C; Değer O; Bostan M; Orem A; Sönmez M; Ulusoy S; Telatar M
Acta Cardiol; 1999 Apr; 54(2):77-81. PubMed ID: 10378018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
